Men whose prostate cancer returns after surgery or radiation therapy may now have a new, life-extending treatment option. A new clinical trial has...
Vous n'êtes pas connecté
Maroc - KNOWRIDGE.COM - A La Une - 25/Oct 15:11
Researchers from UCLA have found a promising new way to help men with recurring prostate cancer live longer without their disease getting worse. In a recent clinical trial, adding a targeted radiation drug before standard treatment more than doubled the amount of time patients remained free of cancer progression. The study, presented at the 2025 […] The post New drug combo may effectively treat recurrent prostate cancer appeared first on Knowridge Science Report.
Men whose prostate cancer returns after surgery or radiation therapy may now have a new, life-extending treatment option. A new clinical trial has...
Men whose prostate cancer returns after surgery or radiation therapy may now benefit from a new drug combination shown in clinical trials to cut the...
For patients suffering from severe and uncontrollable heart rhythm problems, a new study brings promising news. Radiation therapy, usually used to...
WEDNESDAY, Oct. 22, 2025 — A powerful new drug combo has yielded a major breakthrough for men battling an aggressive form of prostate...
Acute myeloid leukaemia, or AML, is one of the most dangerous blood cancers. It spreads quickly and is often hard to treat, especially in older...
Acute myeloid leukaemia, or AML, is one of the most dangerous blood cancers. It spreads quickly and is often hard to treat, especially in older...
A new drug combo of enzalutamide and hormone therapy...
A new drug combo of enzalutamide and hormone therapy...
A new phase 3 trial reveals that combining enzalutamide and leuprolide significantly improves overall survival for men with high-risk recurrent...
As people get older, the muscles in their body begin to stiffen—including the heart. This can lead to a common type of heart failure where the heart...